You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

liver function

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Subjects With Liver Function Injury, Normal Liver Function Subject Trial in Changchun (Deuremidevir Hydrobromide Tablets)

Completed
  • Subjects With Liver Function Injury
  • Normal Liver Function Subject
  • Deuremidevir Hydrobromide Tablets
  • Changchun, Jilin, China
    The First Hospital of Jilin University Ethics Committee
Oct 16, 2023

Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration Trial (High-Dose Insulin Therapy)

Not yet recruiting
  • Liver Dysfunction
  • +2 more
  • High-Dose Insulin Therapy
  • (no location specified)
Nov 6, 2023

Liver and Biliary Tract Disorders in Duration of Pregnancy, Other End-stage Liver Diseases in Children Trial in Chongqing

Completed
  • Liver and Biliary Tract Disorders in Duration of Pregnancy
  • Other End-stage Liver Diseases in Children
    • Chongqing, Chongqing, China
      Children's Hospital of Chongqing Medical University
    Sep 18, 2023

    Burns Trial in Giza (Pulsed electromagnetic therapy group)

    Recruiting
    • Burns
    • Pulsed electromagnetic therapy group
    • Giza, Egypt
      Faculty of Physical therapy, Cairo University
    Nov 14, 2023

    COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)

    Completed
    • COVID-19 Pneumonia
    • GST-HG171 Tablets
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 26, 2023

    Diabetes Trial (Retagliptin Phosphate Tablet)

    Not yet recruiting
    • Diabetes
    • Retagliptin Phosphate Tablet
    • (no location specified)
    Sep 7, 2023

    Liver Diseases Trial in Yangsan (Panax Ginseng C.A. Mey Extract group, Placebo group)

    Recruiting
    • Liver Diseases
    • Panax Ginseng C.A. Mey Extract group
    • Placebo group
    • Yangsan, Korea, Republic of
      Integrated Research Institute for Natural Ingredients and Functi
    Feb 1, 2023

    Hepatic Impairment, Healthy Volunteers Trial in München, Gdansk, Bratislava (NNC0194-0499)

    Not yet recruiting
    • Hepatic Impairment
    • Healthy Volunteers
    • München, Germany
    • +2 more
    Jun 27, 2023

    Liver Function Tests Trial in Mardi?n (exercise (5 minutes warm-up-30 minutes walking-5 minutes cooling down))

    Completed
    • Liver Function Tests
    • exercise (5 minutes warm-up-30 minutes walking-5 minutes cooling down)
    • Mardi̇n, Turkey
      Hülya Keskin
    Nov 10, 2022

    Non-Alcoholic Fatty Liver Disease (NAFLD) Trial in Jakarta Pusat (Proliverenol, Placebo caplets of Proliverenol)

    Recruiting
    • Non-Alcoholic Fatty Liver Disease (NAFLD)
    • Jakarta Pusat, Jakarta, Indonesia
      Division of Hepatology, Dr. Cipto Mangunkusumo Hospital
    Nov 7, 2023

    NSCLC Trial in Chendu (Almonertinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • Chendu, Sichuan, China
      West China Hospital，Sichuan University
    Dec 14, 2022

    Hepatic Impairment Trial in München, Bratislava (Cagrilintide)

    Not yet recruiting
    • Hepatic Impairment
    • München, Germany
    • +1 more
    Nov 10, 2022

    Development and Validation of Point-of-Care Diagnostic Liver

    Recruiting
    • Liver Diseases
    • +3 more
    • Adult
    • Philadelphia, Pennsylvania
      Group K Diagnostics
    Jul 11, 2022

    Healthy, Hepatic Insufficiency Trial in Miami, Orlando, San Antonio (LY3502970)

    Not yet recruiting
    • Healthy
    • Hepatic Insufficiency
    • Miami, Florida
    • +3 more
    May 22, 2023

    Metabolism, Liver Function, Pharmacokinetics Trial in Fort Collins (Cannabidiol (CBD) powder formulation, Cannabidiol (CBD) Oil

    Completed
    • Metabolism
    • +2 more
    • Cannabidiol (CBD) powder formulation
    • +5 more
    • Fort Collins, Colorado
      Colorado State University, Dept. of Health and Exercise Science
    Jun 27, 2022

    Liver Diseases, Hepatic Impairment Trial (PF-07923568)

    Not yet recruiting
    • Liver Diseases
    • Hepatic Impairment
    • (no location specified)
    May 4, 2023

    Hepatic Impairment Trial in Chendu (Yimitasvir Phosphate)

    Completed
    • Hepatic Impairment
    • Yimitasvir Phosphate
    • Chendu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 25, 2022

    Delta Radiomics for Liver Function Evaluation

    Not yet recruiting
    • Chronic Liver Disease
      • Guangzhou, Guangdong, China
        The First Department of Hepatobiliary Surgery, Zhujiang Hospital
      Mar 16, 2022

      Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))

      Recruiting
      • Prevention of Thromboembolic Events
      • +4 more
      • Asundexian (BAY2433334)
      • Kiel, Schleswig-Holstein, Germany
        CRS-Kiel
      Jan 17, 2023

      Gut Microbiota on Postoperative Liver Function Recovery in

      Completed
      • Gut Microbiota
      • Hepatocellular Carcinoma
        • Wuhan, Hubei, China
          The hepatic surgery of Tongji hospital
        May 11, 2022

        Chronic Hepatitis D Infection Trial (Bulevirtide)

        Not yet recruiting
        • Chronic Hepatitis D Infection
        • Bulevirtide
        • (no location specified)
        Mar 1, 2023

        Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

        Not yet recruiting
        • Hepatocellular Carcinoma by BCLC Stage
        • Rennes, France
          Centre Eugene Marquis
        Jan 16, 2023

        Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)

        Recruiting
        • Aplastic Anemia
        • Avatrombopag 20 MG Oral Tablet
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital, Chinese Acade
        Oct 4, 2022

        Healthy, Hepatic Insufficiency Trial in DeLand, Miami, San Antonio (LY3437943)

        Not yet recruiting
        • Healthy
        • Hepatic Insufficiency
        • DeLand, Florida
        • +3 more
        Jun 15, 2023

        Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

        Completed
        • Nonalcoholic Fatty Liver Disease
        • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
        • +3 more
        • Jerusalem, Israel
          Hadassah University Hospital - Ein Kerem
        Sep 13, 2023